3 ms·
You're right; that's sloppy writing in Morris's column. The wording is clearer in the book, which I just looked up via Amazon's search-inside-the-book. From p.
by gojomo 17y ago
You're right; that's sloppy writing in Morris's column. The wording is clearer in the book, which I just looked up via Amazon's search-inside-the-book. From p. 109:
When government bureaucrats ration health care, the results can be a disaster. Take the grim story of colon cancer in Canada. Colorectal cancer rates are much higher in Canada (6.7 per 100,000). than in the United States (4.8 per 100,000.) And although 41 percent of cases in Canada prove fatal, only 34 percent in the United States lead to death.
Even though colorectal cancer is the second leading cause of death in Canada, the drug Avastin -- the standard treatment in the United States -- is not available to patients in Canada through the government health system. "What is going on in Canada is shameful," says Barry D. Stein, president of the Colorectal Cancer Association of Canada. "This treatment, which was finally approved last year in Canada and which was long overdue, is not reaching patients who are desperately in need of... a treatment which is the standard of care in the treatment of the disease."
My point is mainly there are lots of ways to ration -- dragging out both approval and access save money, at the margin, but also result in earlier deaths, at the margin. There are tradeoffs in any system. Some USians would like the Canadian system; some Canadians have to come to the US for treatments.
And especially with regard to the US system, there are big externalities and innovation effects. Canada and the rest of the world get giant positive externalities from the drugs and treatments developed first in the USA's expensive, competitive market. It may be economically rational to dilly-dally on advanced techniques when some other market is leading the way; or to drive a national hard-bargain to get drugs near the cost of production when the drug is already developed. But if every country lags, and every country squeezes all the profit out of medicine, the whole world will suffer from resulting the dearth of innovation.